cataliesw

pd1 and pdl1 in cancer: Immunotherapy presents promising results for cancer treatment in the past few years. PD-1, also known as CD279, is a 55-kDa transmembrane protein containing 288 amino acids. First discovered in 1992, PD-1 served as an inhibitor of both innate and adaptive immune responses. Of note, PD-1 is highly expressed on tumor-specific T cells.

Sign up for our newsletter

Don't miss out. Receive our free weekly newsletter to learn about the best creative work from all around the globe. We're keeping your email safe and confidential.